South Korean researcher Hwang Woo-suk resigned from his position as a university professor on Friday after his school said he had damaged the scientific community by fabricating the results of at least nine of 11 stem-cell lines he claimed to have created.

"I sincerely apologize to the people for creating a shock and disappointment," Hwang told reporters as he was leaving his office at the university. "With an apologetic heart ... I step down as professor of Seoul National University."

Earlier on Friday, a university panel of investigators said Hwang's fabrication was a deliberate deception that has undermined the credibility of science.

The university's announcement of results so far in its investigation into Hwang's work were the first confirmation of allegations that have cast a shadow over all of his purported breakthroughs in cloning and stem-cell technology.

"This kind of error is a grave act that damages the foundation of science," the panel said.

The South Korean government, which had strongly supported Hwang and designated him the country's first "top scientist," said Friday it was "miserable" over the reported results of the investigation and will start its own probe over ethics breaches.

Choi Seong-sik, vice minister of science and technology, said it is impossible to recover money already spent for Hwang, a total $39.9 million for research and facilities since 1998. But his ministry, which admitted errors in its handling of Hwang's projects, will look at ending other funding and withdrawing the "top scientist" designation.

In a May paper published in the journal "Science," Hwang claimed to have created 11 stem-cell lines matched to patients in an achievement that raised hopes of creating tailored therapies for hard-to-treat diseases. But one of his former collaborators last week said nine of the 11 cell lines were faked, prompting reviews by the journal and an expert panel at Seoul National University, where Hwang works as a professor.

The panel said Friday it found that "the laboratory data for 11 stem cell lines that were reported in the 2005 paper were all data made using two stem cell lines in total."

To create fake DNA results purporting to show a match, Hwang's team split cells from one patient into two test tubes for the analysis — rather than actually match cloned cells to a patient's original cells, the university said.

"Based on these facts, the data in the 2005 Science paper cannot be some error from a simple mistake, but cannot be but seen as a deliberate fabrication to make it look like 11 stem-cell lines using results from just two," the panel said.

"There is no way but that Professor Hwang has been involved," the university's dean of research affairs, Roe Jung-hye, told a news conference. He said Hwang "somewhat admits to this."

However, Hwang maintained on Friday that he had still created the technology to create patient-matched stem cells as he had claimed in the May article in Science.

"I emphasize that patient-specific stem cells belong to South Korea and you are going to see this," Hwang said.

The investigating panel said DNA tests expected to be completed within a few days would confirm if the remaining two stem-cell lines it had found were actually successfully cloned from a patient.

In light of the revelations, the panel said it would now also investigate Hwang's other landmark papers — which include another Science article in 2004 on the world's first cloned human embryos, and an August 2005 paper in the journal Nature on the first-ever cloned dog. The journals already are reviewing all the work.

However, he admitted last week to "fatal errors" in the May report and asked Science to withdraw the paper. He acknowledged that at the time of publication, his team had created only eight cell lines. But he said three more were created later.

Professor Alan Trounson, a top stem-cell researcher at Australia's Monash University, said the scandal showed scientists were rigorously checking each other's results. But he predicted the fallout would also stain any other scientists linked to Hwang's work. He also said the South Korean's claim to have cloned a dog was "very much in doubt now."

"I think a lot of the community were very impressed with the cloning of a dog — and it was a delightful dog — but I actually don't think it is a cloned dog now," Trounson told The Associated Press in a telephone interview.

The panel said Friday that it found was no records of two of the other stem-cell lines Hwang claims to have created. Four others died from contamination, and another three were in the nurturing stage and hadn't yet become full stem-cell lines.

Hwang's article this year had also been viewed as significant for his efficiency in cloning the stem-cell lines, claiming to use just 185 human eggs to create custom-made embryonic stem cells for the 11 patients.

But Roe said the investigation had "found that there have been a lot more eggs used than were reported" and were investigating the exact number.

The university had said it was waiting to take action against Hwang until its investigation is complete, but Roe said: "It's hard for Professor Hwang to escape grave responsibility."

The government had stood by Hwang, a veterinarian, when he admitted last month to ethics violations for using eggs from female workers in his lab in research. On Friday, it said it would still support similar research despite the Hwang revelations.

"Despite the recent scandal, the government will continue supporting biotechnology research, including stem cells, so that hopes for stem-cell research by patients with incurable diseases and their families and the public are not in vain," the Ministry of Science and Technology said.

Hwang had last month resigned as head of the World Stem Cell Hub — an international project founded in October that had planned to open centers in Britain and the United States — after admitting he used eggs from female workers at his lab in violation of ethics guidelines. Sung Sang-cheol, head of Seoul National University Hospital where the hub is located, said Friday the center would continue working but might be reorganized or renamed.